Pfizer is at it again – FDA approves new intravenous Monkeypox drug treatment from Pfizer-linked SIGA Technologies.
https://www.thegatewaypundit.com/2022/05/fda-approves-new-intravenous-monkeypox-drug-treatment-pfizer-linked-siga-technologies/
“On Thursday, the US Food and Drug Administration (FDA) announced that it had approved the company’s intravenous version of TPOXX® (tecovirimat) for use in the US to treat monkeypox. The new drug was created by SIGA Technologies, which formed a partnership related to the drug with Meridian Medical Technologies in 2019.
And, sure enough, Meridian is owned by Pfizer.”
Comments
Post a Comment